Additively manufactured medical products – the FDA perspective

Additively manufactured medical products – the FDA perspective

Abstract Additive manufacturing/3D printing of medical devices is becoming more commonplace, a 3D printed drug is now commercially available, and bioprinting is poised to transition from laboratory to market. Despite the variety of technologies enabling these products, the US Food and Drug Administr...

Full description

Bibliographic Details
Main Authors: Matthew Di Prima, James Coburn, David Hwang, Jennifer Kelly, Akm Khairuzzaman, Laura Ricles
Format: Article
Language:English
Published: BMC 2016-12-01
Series:3D Printing in Medicine
Subjects:
Medical Device
Additive Manufacturing
Device Type
Final Device
Solid Oral Dosage Form
Online Access:http://link.springer.com/article/10.1186/s41205-016-0005-9

Internet

http://link.springer.com/article/10.1186/s41205-016-0005-9

Similar Items